top of page

Dacoplice 15 mg Tablet

SKU Pfizer Ltd
原始價格

$504,31

促銷價格

$393,36

Dacoplice 15 mg Tablet is a targeted therapy designed for adults battling advanced or metastatic non-squamous non-small cell lung cancer. This innovative medication serves as a first-line treatment option or can be utilized after conventional chemotherapy has been ineffective. Dacoplice specifically targets tumors with certain genetic mutations, including epidermal growth factor receptor (EGFR) exon 19 deletions or L858R substitutions, which are crucial for treatment eligibility. It is important to note that Dacoplice is not recommended for pediatric patients, as its safety and efficacy in children and adolescents remain unestablished. By inhibiting cancer cell growth, Dacoplice offers hope to those facing challenging diagnoses, promoting better outcomes and quality of life. Always consult with a healthcare professional before starting treatment to discuss potential side effects and ensure the best therapeutic approach tailored to individual needs. With Dacoplice, patients can take a significant step towards managing their condition effectively.

數量

Active Pharmaceutical Ingredient

Dacomitinib 15 mg

Uses

• Dacoplice 15 mg tablet is primarily utilized in the treatment of non-small cell lung cancer (NSCLC). This type of lung cancer is characterized by the uncontrolled growth of cells in the lung tissue. By targeting specific pathways involved in tumor growth, Dacoplice 15 mg tablet helps to manage the progression of the disease. Patients may benefit from this treatment as part of a comprehensive cancer care plan.
• In addition to its primary use, Dacoplice 15 mg tablet can be part of combination therapy for enhanced efficacy. When used alongside other cancer treatments, it may improve overall outcomes for patients with non-small cell lung cancer. This multi-faceted approach allows healthcare providers to tailor treatment strategies based on individual patient needs. Dacoplice 15 mg tablet plays a crucial role in such personalized treatment regimens.
• Dacoplice 15 mg tablet may also be prescribed for patients with advanced stages of non-small cell lung cancer. In these cases, the medication aims to slow down the growth of cancer cells and alleviate symptoms. This can significantly improve the quality of life for patients facing the challenges of advanced cancer. The use of Dacoplice 15 mg tablet is guided by ongoing assessments of treatment response and patient well-being.
• For individuals who have experienced recurrence of non-small cell lung cancer, Dacoplice 15 mg tablet may offer a viable treatment option. It provides an opportunity to manage the disease after initial therapies have been completed. This medicine can help in maintaining disease control and extending survival in patients with recurrent cancer. The incorporation of Dacoplice 15 mg tablet into treatment plans reflects the evolving nature of cancer management.

Benefits

Dacoplice 15 mg Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Dacoplice 15 mg can help to slow the progression of cancer. Dacoplice 15 mg Tablet may be able to help reduce the severity of cancer-related symptoms, such as pain and fatigue, which may improve the patient's overall quality of life. Dacoplice 15 mg Tablet may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.

Side Effects

Like all medications, Dacoplice 15 mg Tablet can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Most Common Side Effects

• Itching
• Breathlessness
• Mouth sores
• Rashes
• Pain
• Cold
• Hair loss
• Dry red itchy eyes
• loss of weight

Common Side Effects

• Kidney disease
• Liver disease
• Respiratory distress
• Asthma, ILD ( interstitial lung disease)
• Skin conditions
• sensitivity, skin fissures, hypertrichosis, skin exfoliation, Keratitis, dehydration
• Stomatitis
• Nausea
• Constipation
• loss of appetite
• cough
• Pain in extremities
• Insomnia
• Alopecia
• Asthenia

How To Use

Dacoplice 15 mg Tablet should be taken on an empty stomach at least one hour before or two hours after a meal. Always take Dacoplice 15 mg Tablet exactly as directed by your doctor, including the recommended number and timing of tablets. Do not change your dose or stop this medicine without consulting your doctor. If you miss a dose, take it as soon as possible. If the next dose is scheduled within 12 hours, skip the missed dose and continue with the regular dosing regimen. It is not recommended to take two doses at the same time. If you overdose on Dacoplice 15 mg, contact your doctor immediately or seek medical help at the nearest hospital emergency department.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Dacoplice 15 mg. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Dacoplice 15 mg Tablet is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Dacoplice 15 mg Tablet is recommended. The use of Dacoplice 15 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Dacoplice 15 mg Tablet. Dacoplice 15 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Dacoplice 15 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Dacoplice 15 mg Tablet is safe for use in patients with mild to moderate liver disease, no dose adjustment of Dacoplice 15 mg Tablet is recommended. The use of Dacoplice 15 mg is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Dacoplice 15 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Dacoplice 15 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Dacoplice 15 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Dacoplice 15 mg.

bottom of page